相关实验视频
Updated: Jun 5, 2025

04:10
Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice
Published on: March 31, 2023
4.3K
奎尔塞丁:一种具有治疗急性肺损伤潜力的黄胺
Ma Huang1, Xinxin Liu1, Yingcong Ren1
1Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi City, Gui Zhou, People's Republic of China.
Drug design, development and therapy
|December 11, 2024
概括
急性肺损伤 (ALI) 缺乏有效的治疗方法. 本综述探讨了天然化合物奎尔素作为潜在的治疗剂,通过检查其对ALI关键病理过程的机制.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 急性肺损伤 (ALI) 是重症监护病房中普遍存在和严重的疾病,其特点是患病率和死亡率高.
- 目前对ALI的治疗策略有限,尽管进行了广泛的研究,但尚未确定任何特定的有效药物.
- Quercetin 是一种天然的黄类化合物,表现出与 ALI 病理相关的多种生物活性和药理效应.
研究的目的:
- 为急性肺损伤 (ALI) 提供奎尔丁潜在治疗应用的全面审查.
- 为了对ALI进行分类,并详细介绍Quercetin可以治疗这种疾病的机制.
- 评估奎尔丁作为ALI的新疗法选择.
主要方法:
- 文献综述和对有关奎尔丁生物活性现有研究的分析.
- 检查氨酸对氧化应激,炎症,铁亡,亡,纤维化和与ALI相关的感染的影响.
- 对ALI的分类和关于奎尔丁治疗机制的信息的综合.
主要成果:
- 奎尔丁证明了调节多个点和涉及ALI的信号通路的能力.
- 它抑制了关键的病理过程,包括氧化应激,炎症反应,铁亡,亡和纤维化.
- 奎尔还显示出对抗与ALI相关的细菌和病毒感染的潜力.
结论:
- 奎尔的多方面的生物活性表明,急性肺损伤 (ALI) 的治疗潜力显著.
- 需要进一步的研究和临床试验来验证奎尔素作为ALI的新型治疗策略.
- 本次审查强调了需要全面了解和探索在重症监护医学中使用诸如奎尔素这样的天然化合物.
相关概念视频
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Flail Chest-II
160
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
160

